'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine

Benjamin Davido; Helene Mascitti; Marc Fortier-Beaulieu; Karim Jaffal; Pierre de Truchis

doi:10.1093/jtm/taab024

'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine

J Travel Med. 2021 Jun 1;28(4):taab024. doi: 10.1093/jtm/taab024.

Authors

Benjamin Davido¹, Helene Mascitti¹, Marc Fortier-Beaulieu¹, Karim Jaffal¹, Pierre de Truchis¹

Affiliation

¹ Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, AP-HP, 104 Bld Raymond Poincare, Garches 92380, France.

Abstract

Highlights: COVID toes can be encountered in young individuals during acute COVID-19 infection while it results from the direct action of Spike protein on vessels. We report the case of COVID toes during the French campaign of vaccination that occurred 4 days after the vaccination with the Pfizer-BioNTech mRNA vaccine against COVID-19.

Keywords: COVID-19; chilblain; toes; vaccine, Pfizer COVID-19 vaccine; adverse events.

MeSH terms

BNT162 Vaccine
COVID-19 / prevention & control*
COVID-19 Vaccines / adverse effects*
Humans
RNA, Messenger
Toes / pathology*
Vaccination

Substances

COVID-19 Vaccines
RNA, Messenger
BNT162 Vaccine